Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials

UCLA's Jonsson Comprehensive Cancer Center

UCLA's Jonsson Comprehensive Cancer Center
JCCC: A Comprehensive Cancer Center
JCCC Member Directory
Calendar
Contact Us
Map and Directions to JCCC
Social Media
Connect via Mobile
Privacy Practices
 
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Noah Federman, M.D.
Noah Federman, M.D.

Specialty:

Pediatric Hematology/Oncology

General Information:

Gender:
Male
Language(s):
English, Spanish

Affiliation(s):

Assistant Professor, Department of Pediatrics, Hematology/Oncology
Director, Pediatric Bone and Soft Tissue Sarcoma Program
Member, JCCC Cancer Nanotechnology Program Area

Hospital Affiliation(s):

Mattel Children's Hospital at UCLA
Ronald Reagan UCLA Medical Center
Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Education:

Fellowship:
Pediatric Hematology-Oncology, UCLA School of Medicine, 2005 - 2008
Residency:
Pediatrics, UCLA School of Medicine, 2003 - 2005
Internship:
Pediatrics, UCLA School of Medicine, 2002 - 2003
Medical Degree:
MD, Mount Sinai School of Medicine, 2002

Certification(s):

Medical Board Certification(s):
Pediatrics, American Board of Pediatrics, 2005
Pediatric Hematology/Oncology, American Board of Pediatrics, 2009

Contact Information:

Phone:
(310) 825 6708
Email:
nfederman@mednet.ucla.edu

Practice Information:

Clinical Interest(s):
Children with bone and soft tissue sarcomas

Scientific Interest(s):

Dr. Noah Federman’s main scientific interest has been in the field of nanotechnology: developing nanoparticles to specifically target sarcomas and deliver cytotoxic chemotherapy. This novel research may lead to new breakthroughs in targeted therapies for cancer. As a member and institutional principle investigator for the Sarcoma Alliance Research Through Collaboration (SARC), Federman leads an experienced pediatric sarcoma clinical research team with an emphasis towards studying promising new agents in children with very aggressive and often fatal metastatic and refractory bone and soft tissue cancers.

Selected Cancer-Related Publications:

Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol. 2009 Apr;10(1-2):82-93. Epub 2009 Feb 24.

Benz MR, Tchekmedyian N, Eilber FC, Federman N, Czernin J, Tap WD. Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol. 2009 Jul;21(4):345-51.

Federman N, Sakamoto K. Nonrhabdomyosarcoma soft tissue sarcomas. Emedicine. Dec 2008.

Tap WD, Federman N, Eilber FC. Targeted therapies for soft-tissue sarcomas. Expert Rev Anticancer Ther. 2007 May;7(5):725-33.

Federman N, Feig SA. PET/CT in evaluating pediatric malignancies: a clinician's perspective. J Nucl Med. 2007 Dec;48(12):1920-2.

In the News: